» Articles » PMID: 26608605

High Frequency Deep Brain Stimulation and Neural Rhythms in Parkinson's Disease

Overview
Specialties Neurology
Psychology
Date 2015 Nov 27
PMID 26608605
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

High frequency (HF) deep brain stimulation (DBS) is an established therapy for the treatment of Parkinson's disease (PD). It effectively treats the cardinal motor signs of PD, including tremor, bradykinesia, and rigidity. The most common neural target is the subthalamic nucleus, located within the basal ganglia, the region most acutely affected by PD pathology. Using chronically-implanted DBS electrodes, researchers have been able to record underlying neural rhythms from several nodes in the PD network as well as perturb it using DBS to measure the ensuing neural and behavioral effects, both acutely and over time. In this review, we provide an overview of the PD neural network, focusing on the pathophysiological signals that have been recorded from PD patients as well as the mechanisms underlying the therapeutic benefits of HF DBS. We then discuss evidence for the relationship between specific neural oscillations and symptoms of PD, including the aberrant relationships potentially underlying functional connectivity in PD as well as the use of different frequencies of stimulation to more specifically target certain symptoms. Finally, we briefly describe several current areas of investigation and how the ability to record neural data in ecologically-valid settings may allow researchers to explore the relationship between brain and behavior in an unprecedented manner, culminating in the future automation of neurostimulation therapy for the treatment of a variety of neuropsychiatric diseases.

Citing Articles

Movement-related increases in subthalamic activity optimize locomotion.

Callahan J, Morales J, Atherton J, Wang D, Kostic S, Bevan M Cell Rep. 2024; 43(8):114495.

PMID: 39068661 PMC: 11407793. DOI: 10.1016/j.celrep.2024.114495.


Deep brain stimulation pulse sequences to optimally modulate frequency-specific neural activity.

Farooqi H, Vitek J, Escobar Sanabria D J Neural Eng. 2024; 21(3).

PMID: 38843788 PMC: 11191056. DOI: 10.1088/1741-2552/ad54f0.


Multielectrode Cortical Stimulation Selectively Induces Unidirectional Wave Propagation of Excitatory Neuronal Activity in Biophysical Neural Model.

Halgren A, Siegel Z, Golden R, Bazhenov M J Neurosci. 2023; 43(14):2482-2496.

PMID: 36849415 PMC: 10082457. DOI: 10.1523/JNEUROSCI.1784-21.2023.


The effects of electrical stimulation on glial cell behaviour.

Tsui C, Lal P, Fox K, Churchward M, Todd K BMC Biomed Eng. 2022; 4(1):7.

PMID: 36057631 PMC: 9441051. DOI: 10.1186/s42490-022-00064-0.


Dynamics of phase oscillator networks with synaptic weight and structural plasticity.

Chauhan K, Khaledi-Nasab A, Neiman A, Tass P Sci Rep. 2022; 12(1):15003.

PMID: 36056151 PMC: 9440105. DOI: 10.1038/s41598-022-19417-9.


References
1.
Beurrier C, Bioulac B, Audin J, Hammond C . High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. J Neurophysiol. 2001; 85(4):1351-6. DOI: 10.1152/jn.2001.85.4.1351. View

2.
Grill W, Snyder A, Miocinovic S . Deep brain stimulation creates an informational lesion of the stimulated nucleus. Neuroreport. 2004; 15(7):1137-40. DOI: 10.1097/00001756-200405190-00011. View

3.
Loher T, Burgunder J, Pohle T, Weber S, Sommerhalder R, Krauss J . Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. J Neurosurg. 2002; 96(5):844-53. DOI: 10.3171/jns.2002.96.5.0844. View

4.
Ray N, Jenkinson N, Wang S, Holland P, Brittain J, Joint C . Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. Exp Neurol. 2008; 213(1):108-13. DOI: 10.1016/j.expneurol.2008.05.008. View

5.
Priori A, Foffani G, Pesenti A, Tamma F, Bianchi A, Pellegrini M . Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease. Exp Neurol. 2004; 189(2):369-79. DOI: 10.1016/j.expneurol.2004.06.001. View